Home › Funds › Renaissance Technologies › SGMT
Renaissance Technologies position in SGMT
SAGIMET BIOSCIENCES INC · Health Care
Latest position (Q2 2026)346.93K sh
Reported value held$2.68M
Portfolio Weight0.00%
First reportedQ4 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 23.00K | $125 | New |
| Q1 2024 | 419.40K | $2.27K | Add |
| Q2 2024 | 242.40K | $829.01K | Reduce |
| Q3 2024 | 231.10K | $640.15K | Reduce |
| Q4 2024 | 10.80K | $48.60K | Reduce |
| Q2 2025 | 30.90K | $235.46K | New |
| Q3 2025 | 161.40K | $1.11M | Add |
| Q4 2025 | 342.50K | $2.03M | Add |
| Q1 2026 | 625.47K | $3.27M | Add |
| Q2 2026 | 346.93K | $2.68M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SGMT
- BlackRock Inc 6.58M sh · $50.83M · Q2 2026
- Balyasny Asset Management 3.63M sh · $28.03M · Q2 2026
- Geode Capital Management 1.44M sh · $11.17M · Q2 2026
- Vanguard Group 1.26M sh · $7.46M · Q4 2025
- Millennium Management 937.02K sh · $7.24M · Q2 2026
- Goldman Sachs Group 759.09K sh · $5.87M · Q2 2026
- Hillhouse Capital (HHLR Advisors) 724.80K sh · $5.60M · Q2 2026
- Northern Trust Corp 468.38K sh · $3.62M · Q2 2026
- Farallon Capital Management 415.00K sh · $3.21M · Q2 2026
- UBS Group AG 339.93K sh · $2.63M · Q2 2026
- Citadel Advisors 289.93K sh · $2.24M · Q2 2026